Broader reach with clinical sites across the U.S.
Unlike traditional site management organizations (SMO’s), PhaseWell Research owns sites in addition to embedding research within other curated sites in its network.
View our site locations
#1 PhaseWell Research HQ
The PhaseWell Research corporate office is in Nashville, TN. This building is used for administrative purposes and is not a patient-facing clinic.
#2-4 Renstar Medical Research
Located in Ocala, FL, 90 minutes from Tampa/Orlando, Renstar Medical Research has 3 distinct locations. Collectively, it has conducted more than 700 clinical research studies since its founding in 1997. Renstar excels at high-quality, community-centric research across a range of therapeutic areas, including Central Nervous System Disorders, Metabolic Diseases, and Dermatology. Pin# 2 location is for administration purpose and is not a clinic.
#5 Gabrail Cancer Center Research
Founded in 1990, Gabrail Cancer Center Research is located in Canton, OH, 60 minutes from Cleveland. Led by Dr. Nash Gabrail, GCCR has conducted more than 200 Phase I and 500 Phase II-IV oncology studies and has a dedicated Phase 1 unit with 16 beds. GCCR also supports Sargon Research, an oncology embedded research network with 6 sites across the US.
#6 Carolina Cancer Research Center
Located 60 minutes from the Raleigh/Durham/Chapel Hill area, Carolina Cancer Research Center, a Sargon Research site, unites oncology care and quality research led by Dr. Keith Lerro of Regional Medical Oncology Center.
#7-11 Sargon Research - Ready to Enroll
Sargon Research, powered by Gabrail Cancer Center Research, is expanding its clinical research footprint with new sites preparing to launch research across key regions. Sargon provides a robust operational infrastructure – including contracting, budgeting, regulatory guidance, compliance oversight, patient recruitment support, data management, and billing services.
Each site reflects Gabrail Cancer Center Research’s commitment to advancing quality oncology research through community partnerships. These locations contribute to a network dedicated to bringing innovative clinical trials closer to patients. Stay tuned as we onboard and activate these new sites.
Selection of sites for success
PhaseWell Research is experienced at selecting ideal clinical trial sites for its network to be successful. This involves conducting deep due diligence across study successes within a therapeutic area, site capabilities and infrastructure, patient population, expertise of staff, cultural fit, and proven compliance and regulatory requirements.
This in turn ensures consistency of optimal trial execution across all
PhaseWell Research enabled sites.